Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Shengtai Pharmaceutical, Inc. Chairman Withdraws Preliminary Offer to Take Company Private and Dissolves Special Committee PR Newswire WEIFANG, China, Aug. 7, 2013 WEIFANG, China, Aug. 7, 2013...
Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results PR Newswire WEIFANG, SHANDONG, China, May. 15, 2013 WEIFANG, SHANDONG, China, May. 15, 2013 /PRNewswire/...
Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 Financial Results PR Newswire WEIFANG, SHANDONG, China, Feb. 14, 2013 WEIFANG, SHANDONG, China, Feb. 14, 2013 /PRNewswire/...
Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2013 Financial Results /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a {...
The Rosen Law Firm is investigating the Board of Directors of Shengtai Pharmaceutical Inc. (OTC: SGTI) for possible breaches of fiduciary duty and other violations of state law...
Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012 PR Newswire WEIFANG, Shandong, China, Sept. 28, 2012 WEIFANG, Shandong, China, Sept. 28, 2012 /PRNewswire/...
Shengtai Pharmaceutical, Inc. Special Committee Selects Financial and Legal Advisors PR Newswire WEIFANG, Shandong, China, June 23, 2012 WEIFANG, Shandong, China, June 23, 2012...
Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results PR Newswire WEIFANG, China, May 16, 2012 WEIFANG, China, May 16, 2012 /PRNewswire-Asia/ -- Shengtai...
Shengtai Pharmaceutical, Inc. Establishes Special Committee to Evaluate Non-binding Going Private Proposal PR Newswire WEIFANG, China, April 23, 2012 WEIFANG, China, April 23, 2012...
Levi & Korsinsky is investigating the Board of Directors of Shengtai Pharmaceutical, Inc. (“Shengtai” or the “Company”) (OTC: SGTI) for possible breaches of fiduciary duty and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 14231 | 1.0E-6 | CS |
| 156 | -0.024999 | -99.996 | 0.025 | 0.025 | 1.0E-6 | 14963 | 1.0E-6 | CS |
| 260 | -0.010499 | -99.9904761905 | 0.0105 | 0.037 | 1.0E-6 | 10644 | 0.01753606 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
